South Korea Single-Use Bioreactors Market (2026-2031)
The South Korea Single-Use Bioreactors Market was valued at $129.7 Million in 2026 and projected to reach to $243.5 Million by 2031, representing a compound annual growth rate of 13.4%. South Korea's single-use bioreactors market is poised for sustained growth through 2031, driven by the country's expanding biopharmaceutical manufacturing capabilities and increasing adoption of disposable bioprocessing technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Single-Use Bioreactors Market Trends and Insights
- South Korea's biopharmaceutical sector is increasingly adopting single-use bioreactor technology to enhance manufacturing flexibility and reduce contamination risks.
- The market growth in South Korea is driven by rising demand for biologics, government support for biotech innovation, and the country's established contract manufacturing organization (CMO) ecosystem. South Korea's position as a leading biotech hub in Asia Pacific is accelerating single-use bioreactor adoption across vaccine production, monoclonal antibody manufacturing, and cell therapy applications.
- South Korea's regulatory environment and investment in advanced manufacturing infrastructure are creating favorable conditions for market expansion.
- By 2031, South Korea is expected to solidify its role as a key regional player in single-use bioreactor deployment, supported by continuous technological advancement and increased biopharmaceutical production capacity..
Key Market Statistics
- CAGR (2026-2031) 13.4% CAGR
- Market Size, 2026 ~USD 129.7 Million
- Forecast, 2031 ~USD 243.5 Million
- Country South Korea
South Korea Single-Use Bioreactors Market Overview
Market Valuation Growth :
South Korea's single-use bioreactors market is valued at USD 129.7 million in 2026, with a strong projected CAGR of 13.4%, reaching USD 243.5 million by 2031, outpacing the global average of 12%.
Biopharmaceutical Sector Adoption :
South Korea's biopharmaceutical industry is rapidly adopting single-use bioreactor technology to enhance manufacturing flexibility, reduce contamination risks, and accelerate time-to-market for biologics and biosimilars.
Regional Manufacturing Hub :
South Korea's position as a leading biopharmaceutical manufacturing hub in Asia-Pacific is driving increased investment in single-use bioreactor infrastructure and capacity expansion among domestic and multinational companies.
Regulatory Support & Innovation :
South Korean regulatory frameworks and government initiatives supporting biotech innovation are fostering market growth, with increased R&D investments in cell therapy, monoclonal antibodies, and recombinant protein production.
South Korea Single-Use Bioreactors Market Dynamics
- The market benefits from South Korea's strong biotech ecosystem, government support for life sciences innovation, and rising demand for cost-effective, flexible manufacturing solutions among local and international biopharmaceutical companies. Key growth drivers include the surge in biosimilar production, cell and gene therapy development, and the need for rapid scale-up capabilities in response to global demand.
- South Korea's skilled workforce, advanced infrastructure, and strategic location in Asia-Pacific position it as a preferred manufacturing destination, further accelerating single-use bioreactor adoption and market expansion through the forecast period..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- South Korea's single-use bioreactors market is projected to grow from USD 129.7 million in 2026 to USD 243.5 million by 2031, representing a 13.4% CAGR.
- South Korea's biopharmaceutical industry is driving adoption of single-use bioreactors for improved manufacturing efficiency and reduced operational costs.
- South Korea's government initiatives and biotech ecosystem support accelerated market penetration across vaccine, monoclonal antibody, and cell therapy sectors.
- South Korea's CMO sector expansion and regulatory support position the country as a critical regional hub for single-use bioreactor technology deployment.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
South Korea Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Bioreactor Equipment Manufacturers : Manufacturers need South Korea market data to assess growth opportunities, identify customer segments, and develop region-specific product strategies for single-use bioreactor systems and components.
- Biopharmaceutical Companies : South Korean and international biopharmaceutical firms require market insights to evaluate manufacturing capacity investments, technology adoption decisions, and competitive positioning in the region's growing biotech sector.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in South Korea need market intelligence to justify capacity expansion, technology upgrades, and service offerings aligned with increasing demand for single-use bioprocessing solutions.
- Investment & Private Equity Firms : Investors targeting South Korea's biotech sector require detailed market data to identify investment opportunities, assess portfolio company growth potential, and evaluate market dynamics and competitive landscapes.
- Regulatory & Consulting Bodies : Regulatory agencies, consultants, and policy advisors need comprehensive market analysis to inform biotech policy development, industry standards, and strategic recommendations for South Korea's biopharmaceutical sector.
Reasons to Buy this Report
- Market-Specific Growth Projections : Access detailed forecasts for South Korea's single-use bioreactors market with precise valuation data (2026-2031), enabling accurate business planning and investment decisions tailored to this high-growth regional market.
- Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, local manufacturer strategies, and market consolidation trends to identify partnership opportunities and competitive positioning within the region's biopharmaceutical ecosystem.
- Regulatory & Policy Insights : Gain comprehensive understanding of South Korean regulatory frameworks, government biotech initiatives, and policy drivers shaping single-use bioreactor adoption and manufacturing investment decisions.
- End-User Demand Analysis : Identify specific demand drivers from South Korea's biopharmaceutical companies, contract manufacturers, and research institutions to align product offerings and market entry strategies with regional customer needs.
- Strategic Market Entry Planning : Leverage South Korea-specific market data to develop targeted go-to-market strategies, distribution partnerships, and localization approaches for maximizing market penetration in this high-potential Asian biotech hub.
Frequently asked questions
What is the current market size of single-use bioreactors in South Korea?
South Korea's single-use bioreactors market was valued at USD 129.7 million in 2026 and is expected to grow to USD 243.5 million by 2031.
What is the projected growth rate for South Korea's single-use bioreactors market?
South Korea's single-use bioreactors market is projected to grow at a compound annual growth rate (CAGR) of 13.4% from 2026 to 2031.
Which applications are driving single-use bioreactor adoption in South Korea?
South Korea's adoption is primarily driven by vaccine production, monoclonal antibody manufacturing, and cell therapy applications within the biopharmaceutical sector.
Why is South Korea a key market for single-use bioreactors?
South Korea's established biotech ecosystem, government support for innovation, robust CMO sector, and strong biopharmaceutical industry make it a strategic market for single-use bioreactor technology.
What factors are supporting market growth in South Korea?
South Korea's market growth is supported by rising biologics demand, regulatory support, manufacturing infrastructure investment, and the country's position as a leading Asia Pacific biotech hub.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
